Efficacy and Safety of a Purified Standardised Bee Venom Preparation

Allergopharma

Status and phase: Completed; Phase 3

Conditions: Bee Venom Allergy

Treatments: Biological: bee venom

Study type: Interventional

Funder types: Industry

Identifiers

NCT00263952

Al0202ig

Details and patient eligibility

About

The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• History of bee venom allergy,
• Positive RAST for bee venom,
• Positive skin prick test for bee venom

Exclusion criteria

• Serious chronic diseases

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)